GSK241220C29000
- 0.00
- 0.000.00%
GlaxoSmithKline Newsroom
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)
What's Going On Moderna Stock On Monday?
GSK's Jemperli Recommended for Expanded Approval in Endometrial Cancer, Receives Breakthrough Therapy Designation for Rectal Cancer
GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK
GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA
GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission
ViiV Healthcare Announces CHMP Positive Opinion for Vocabria + Rekambys, the First and Only Complete Long-acting HIV Treatment, for Adolescents in Europe
Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer
GSK's B7-H3-targeted Antibody-drug Conjugate, GSK'227, Receives EMA Priority Medicines (PRIME) Designation in Relapsed Extensive-stage Small-cell Lung Cancer
Jemperli (Dostarlimab) Receives US FDA Breakthrough Therapy Designation for Locally Advanced DMMR/MSI-H Rectal Cancer
United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
Barclays Remains a Hold on GlaxoSmithKline (GSK)
Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More
Anaptys Scraps Development of ANB032, Stock Plunges 33%
TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45
GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?
GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
India Drug Delivery Devices Market 2024, With Profiles of Pfizer, Novartis, GlaxoSmithKline, India Medtronic, Cardinal Health, B. Braun Medical, Sun Pharmaceutical, 3M, Cipla & Bayer Zydus Pharma